CJC-1295 research guide for Givonne. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
CJC-1295 Near Givonne — What Researchers Need to Know
For anyone in Givonne looking to source CJC-1295, the foundational reality is that this compound moves through online research channels. This matters because CJC-1295 quality differs enormously across the market — from analytically confirmed high-purity product to products with serious contamination — and the vendor controls every quality variable. What consistently distinguishes top CJC-1295 vendors is comprehensive lot-matched testing data: HPLC for purity, mass spec for identity and weight verification, and endotoxin testing for safety screening. The sections below cover what Givonne researchers need to know about purchasing, testing, and working with CJC-1295 for legitimate research applications.
CJC-1295 Mechanisms Explained
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Givonne researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
CJC-1295 Purchasing Guide
Before looking at individual vendors, build a clear picture of what a proper COA looks like — so you can identify whether a supplier meets the standard. The HPLC analytical chromatogram is the most important document in the COA: it should show a clear dominant peak representing CJC-1295, with small or absent impurity peaks representing impurities — purity should be stated as ≥98%. Strong quality indicators beyond COA quality: multi-year operating history, responsive technical support who understand testing methodology, and temperature-appropriate packaging with desiccant. For Givonne researchers making a first CJC-1295 purchase: apply these quality criteria before ordering, order conservatively at first, and check that batch numbers on your vial match the COA before use.
Order CJC-1295 — ships to Givonne
COA-verified · International tracking · Research grade
CJC-1295 is sold for research purposes only and is not approved for human therapeutic use by the FDA or comparable health authorities — all information here is for educational purposes only. Proper handling of CJC-1295 requires strict sterile technique during reconstitution — alcohol-swabbed septum, fresh needles, clean working environment — and consistent cold chain handling. Quality CJC-1295 sourcing is not separable from research safety — bacterial endotoxin contamination, wrong peptide identity, and degraded material are all safety issues that proper COA verification addresses. PubMed represent the most comprehensive research databases for CJC-1295 research; focus on peer-reviewed publications with documented compound quality over conference abstracts or single case observations.
Frequently Asked Questions
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
